We are an interdisciplinary R&D company, based in Copenhagen Denmark. We develop a software platform to support the treatment of remotely monitored heart patients. Specifically, a mobile app that lets patients take action on their disease from home and a clinical web platform that uses advanced analytics to predict worsening.
Rehfeld Medical was founded in 2014 as a spin-out from R&D at the University of Copenhagen (see www.scaut.dk). Our core product springs from the PhD-research of our two founders, carried out from 2008-2014. We run on both private and public funding.